Close Menu
April 13, 2021
Sponsored by
Beckman Coulter Life Sciences

An Opportunity Arises from the Pandemic: The Promise of Targeted NGS for SARS-CoV-2 Detection

GenomeWebinar

Chief Scientific Officer, Fry Laboratories

Mitigation of the SARS-CoV-2 pandemic will continue to require innovative solutions. This webinar will outline how Fry Laboratories rapidly redeployed a next-generation sequencing (NGS) pipeline originally created for the detection and identification of bacterial, eukaryotic, and fungal infections in response to SARS-CoV-2.

NGS offers unbiased microbial detection while leveraging the analytical and cost-effectiveness advantages of PCR-based methods. This represents a relatively untapped resource, but the approach creates several unique implementation challenges and solutions. 

In this webinar, Jeremy Ellis of Fry Laboratories will describe an ultra-high-throughput SARS-CoV-2 detection assay for as many as 1,152 saliva samples using a single MiSeq Micro flow cell. The assay uses PCR to simultaneously amplify, index, and adapt SARS-CoV-2 specific regions for sequencing. This method enables a significantly higher assay throughput than what is realized by standard PCR-based approaches and allows for the inclusion of additional targets for relevant SARS-CoV-2 mutations of interest as needed. 

Dr. Ellis will describe how his work at Fry Laboratories, in collaboration with Beckman Coulter Life Sciences, is using economical and nimble NGS-based assays to fill gaps in its capabilities as it works to reduce the impact of SARS-CoV-2. 

He will also discuss how the combined capabilities across prokaryotic, eukaryotic, and viral detection using a unified NGS-based technology enabled by scalable solutions represents a new horizon in molecular microbiology.

Sponsored by

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

Apr
21
Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies. 

Apr
27
Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

Apr
28
Sponsored by
Akoya Biosciences

Single-cell omics assays have become essential tools for identifying and characterizing cell types and states of complex tissues. While each single-modality assay reveals distinctive features about the sequenced cells, true multiomics assays are still in the early stage of development. 

May
04
Sponsored by
Akoya Biosciences

Recently developed technologies for digital imaging and highly multiplexed immunohistochemistry (mIHC) advancing the field of histology into a quantitative era, allowing for more complex descriptions of tissue architecture.